Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Concise review: preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade?|
|Citation:||Stem Cells, 2013; 31(6):1040-1043|
|Wai Khay Leong, Martin D. Lewis and Simon A. Koblar|
|Abstract:||Stroke, a debilitating brain insult, afflicts millions of individuals globally each year. In the last decade, researchers have investigated cell-based therapy as an alternative strategy to improve neurological outcome following stroke. This concise review critically examines preclinical reports using human adult and fetal stem/progenitor cells in rodent models of ischemic stroke. As we enter the second decade of study, we should aim to optimize our collective likelihood to translational success for stroke victims worldwide. We advocate international consensus recommendations be developed for future preclinical research.|
|Keywords:||Cell-bsed therapy; middle cerebral artery occlusion; rat model; human stem/progenitor cells; ischemic stroke|
|Rights:||Copyright © 2013 AlphaMed Press|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.